Advertisement

Topics

Latest Assays NewsRSS

23:55 EDT 22nd September 2017 | BioPortfolio

CORRECTING and REPLACING Agilent Technologies Receives Expanded FDA Approval for the Use of Dako PD-L1 IHC 22C3 pharmDx Companion Diagnostic in Gastric or Gastroesophageal Junction (GEJ) Cancer

Patients with gastric or GEJ adenocarcinoma whose tumors express PD-L1 can now be identified for potential treatment with KEYTRUDA® (pembrolizumab) using PD-L1 IHC 22C3 pharmDx Third paragraph of release should read: The expanded approvals for PD-L1 IHC 22C3 pharmDx and KEYTRUDA means that these patients now have the possibility of receiving a targete...

Agilent Technologies Receives Expanded FDA Approval for the Use of Dako PD-L1 IHC 22C3 pharmDx Companion Diagnostic in Gastric or Gastroesophageal Junction (GEJ) Cancer

Patients with gastric or GEJ adenocarcinoma whose tumors express PD-L1 can now be identified for potential treatment with KEYTRUDA® (pembrolizumab) using PD-L1 IHC 22C3 pharmDx Agilent Technologies Inc. (NYSE: A) today announced its Dako PD-L1 IHC 22C3 pharmDx assay has an expanded label approved by U.S. Food and Drug Administration (FDA), for use as ...

Krystal Microplate Enables Development of Drug Testing Assay for Plasmodium vivax

Porvair Sciences reports that the National Center for Biological Sciences (NCBS) in Bangalore, India is using its Krystal 384 black microplate to produce a standard drug testing assay for Plasmodium vivax infection. The NCBS is a leading national institute whose faculty members undertake research in the frontier areas of biology. Scientists at the NCBS use experimental and computational approaches...

#jobs #lifescience Immunocore: Cellular Assay Development Scientist

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Immunocore: Cellular Assay Development Scientist . Competitive: Immunocore: Immunocore, is an innovative and dynamic biotechnology company developing a unique platform of T Cell antigen receptor-based therapeutics. Oxford from … Continue reading → Cet article #jobs...

Chagas Seroprevalence in Military Personnel in Texas

A cross-sectional study of military trainees and instructors who spend significant time in field conditions was performed at Joint Base San Antonio to determine the prevalence of Trypanosoma cruzi infection. None tested positive by polymerase chain reaction nor by enzyme-linked immunosorbent assay or indirect immunofluorescent antibody.

New Assay Leads To Step Toward Gene Therapy For Deaf Patients, Oregon State University Study

  Life Sciences Jobs   ...

Multiple Honors and Recognition for Genomind® as Record of Success Continues

KING OF PRUSSIA, Pa., Sept. 19, 2017 /PRNewswire/ -- Genomind, a personalized medicine company focused on improving mental healthcare through genetic testing, continues to collect a notable set of awards as it builds on its strategic plan. Inc. magazine named Genomind to its Inc. 5000 list of the fastest-growing private firms in America. It cited Genomind's impressive 157 percent growth...

InDevR Licenses Mount Sinai Influenza Antibodies for VaxArray® Neuraminidase Potency Assay

BOULDER, Colo., Sept. 19, 2017 /PRNewswire/ -- InDevR, a Boulder-based progressive analytical technology and life science instrumentation company today announced that it has entered into an exclusive, world-wide license agreement for monoclonal antibodies developed by scientists at the Icahn School of Medicine at Mount Sinai. The license agreement with Mount Sinai will provide InDevR wit...

Rapid Antibiotic Susceptibility Assay for TB Is in the Works

An investigational assay offers rapid antimicrobial susceptibility testing for Mycobacterium tuberculosis directly from sputum samples.

InDevR Licenses Influenza Antibodies For VaxArray Neuraminidase Potency Assay

  Life Sciences Jobs   ...

Ncardia Established Following Pluriomics Axiogenesis Merger

Builds foundation to become the trusted leader in hiPSC based drug discovery solutions Ncardia (www.ncardia.com) has been established following the merger of Pluriomics and Axiogenesis. The privately held company with operations in Europe and the US, produces and commercializes high-quality, fully functional hiPSC derived

Quidel Announces Revised Agreement For Its Pending Acquisition Of Alere???s B-Type Naturietic Peptide (BNP) Assay Business Run On Beckman Coulter Analyzers

  Life Sciences Jobs   ...

Quanterix Corp Product Pipeline Analysis, 2017 Update [Report Updated: 28072017] Prices from USD $750

SummaryQuanterix Corp Quanterix is a medical equipment provider that offers proteins measurement solutions. The company's products comprise simoa HD1 analyzer, assay kits and consumables. It provides assay kits such as Cpeptide simoa assay kit, homebrew assay kit, homebrew bead and SBG kit, PSA simoa assay kit, tau simoa assay kit and TNFa simoa assay kit. Quanterix's products are used in life sci...

Agilent Obtains U.S. FDA Approval for GenetiSure Dx Postnatal Assay

Assay Detects Genetic Anomalies and Helps Move Inquiries from Cause to Care Faster Agilent Technologies Inc. (NYSE: A) has announced that it has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the GenetiSure Dx Postnatal Assay: its first comparative genomic hybridization (CGH) assay for diagnostic use. This assay enables ...

Bio-Techne Introduces a New Luminex Multi-analyte Assay Kit

MINNEAPOLIS, Sept. 13, 2017 /PRNewswire/ -- R&D Systems, a Bio-Techne brand, today announced the release of its new XL Cytokine Discovery Luminex® High Performance Panel.  As with all R&D Systems® Luminex Assays, this new panel is compatible with all Luminex instrumentation systems and has the capability to simultaneously measure the amount of 45 different analytes in a variety of s...

ReachBio Celebrates 10 Years in Business

SEATTLE, Sept. 12, 2017 /PRNewswire/ -- ReachBio Research Labs (trade name under ReachBio LLC), a CRO specializing in primary cell assay services and products, is celebrating 10 years of business success in September. When ReachBio started back in 2007, the company offered primarily hematopoietic colony-forming assay services for drug development clients. Today, the company has evolved a...

DiaSorin Molecular Receives FDA Clearance for Reliable C. Difficile Assay on LIAISON® MDX Platform

The new assay runs on the company’s LIAISON® MDX qPCR system, a scalable benchtop instrument that delivers qualitative and quantitative, sample-to-answer, multi-analyte results

#jobs #lifescience Scientist (Assay Development)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Scientist (Assay Development) .CA-Menlo Park, Based in the Menlo Park area we are an exciting biotech startup! Currently we are looking for a Scientist with Assay Development experience … Continue reading → Cet article #jobs #lifescience Scientist (Assay Developmen...

Indigo Biosciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23082017] Prices from USD $250

SummaryIndigo Biosciences Inc Indigo is a provider of preclinical contract research services for pharmaceutical research and development, biotechnology sectors. The company's products include assay kit platforms and formats, nuclear receptor, signaling pathway, and cell viability assay products, mitochondrial function products, and luciferase detection reagents. Its other products comprise assay a...

Foundation Medicine to Present Validation Data for Its Assay Measuring Tumor Mutational Burden in Blood (bTMB), a New, Non-Invasive Predictor of Response to Immunotherapy

--Data Supports Inclusion of the bTMB Assay into a Phase III Clinical Trial of Atezolizumab Immunotherapy in Individuals with Advanced Lung Cancer-- Foundation Medicine, Inc. (NASDAQ:FMI) today announced presentations at the European Society for Medical Oncology (ESMO) Annual Meetin

Singulex Receives New, Broad Patent For Digital Detection Of Cardiac Troponin-I Or Cardiac Troponin-T For Coronary Artery Disease Rule-Out

ALAMEDA, Calif., Sept. 8, 2017 /PRNewswire/ -- Singulex announced today the granting of a significant patent for determining the absence of coronary artery disease (CAD) in a patient based upon digital detection of either cardiac troponin-I (cTnI) or cardiac troponin-T(cTnT). The patent covers counting individual digital events wherein each individual digital event comprises a signal represen...

Roche announces progress in biomarker science in cancer immunotherapy at the European Society for Medical Oncology Congress

Roche announced today that the first data on a novel blood-based assay, co-developed with Foundation Medicine (NASDAQ: FMI), will be presented during the European Society for Medical Oncology (ESMO) Congress from 8-12 September 2017 in Madrid, Spain.

Foundation Medicine, Inc. To Present Validation Data For Its Assay Measuring Tumor Mutational Burden In Blood (Btmb), A New, Non-Invasive Predictor Of Response To Immunotherapy

  Life Sciences Jobs   ...

Dimerix Bioscience Pty Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 26072017] Prices from USD $250

SummaryDimerix Bioscience Pty Ltd Dimerix, a subsidiary of Sun Biomedical Ltd is a biopharmaceutical company that offers drug discovery assays and progressing clinical programs. The company provides product development, discovery services, and others. It provides ReceptorHIT a cellbased assay applied to the stages of the drug development process. Dimerix's heteromer identification technology assay...

Bio-Techne Releases A Highly Sensitive and Specific Serological Assay to Detect Zika Virus Infections

MINNEAPOLIS, Sept. 6, 2017 /PRNewswire/ -- R&D Systems®, a Bio-Techne brand, announced today the release of a new rapid, solid phase, enzyme-linked immunosorbent assay (ELISA) designed to measure anti-Zika virus immunoglobulin G (IgG) antibodies in human serum. A unique feature of this assay is that, prior to performing the test, samples are pre-treated with a proprietary reagent designe...

Quick Search
Advertisement
 

review and buy Assays market research data and corporate reports here